RxDoctor Payments Data

Jaclyn Farino, NP

Adult Health · Central Islip, NYNPI 1518486877

Payments from drug & device makers

$428in general payments, 2019–2025

Across 21 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$113
  • Neurocrine Biosciences, Inc.$108
  • Amarin Pharma, Inc.$59
  • Pfizer$34
  • Lundbeck LLC$34
  • Teva Pharmaceuticals USA, Inc.$31
  • plus $49 from 2 others

What the payments were for

  • Food & beverage$428100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$428 in reported general payments places this provider in the 50th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$552
Medicare patients
39
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VascepaIcosapent Ethyl102$38,167
JanuviaSitagliptin Phosphate40$25,237
Icosapent Ethyl51$11,735
JardianceEmpagliflozin16$10,272
FarxigaDapagliflozin Propanediol12$8,207
MyrbetriqMirabegron11$5,327
GemtesaVibegron11$5,230
Atorvastatin Calcium392$3,445
Levothyroxine Sodium341$3,238
Rosuvastatin Calcium118$3,202
Albuterol Sulfate HfaAlbuterol Sulfate50$2,063
Omeprazole230$1,785
Lactulose56$1,460
Montelukast Sodium112$1,363
Levocarnitine12$1,346

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$19$25,23740 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,828 adult health providers in New York.

Other adult health in Central Islip

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →